6505--Radiopharmaceutical Vizamyl for the Dayton OH VA (Flutemetamol F 18 Injection)

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 has issued a Special Notice regarding a sole-source procurement of Radiopharmaceutical Vizamyl (Flutemetamol F 18 Injection) for the Dayton Veterans Affairs Medical Center in Ohio. The VA intends to negotiate exclusively with Medi-Physics, Inc. dba GE HealthCare under Federal Acquisition Regulation authority 6.302-1(a)(2), which permits sole-source procurement when only one responsible source can satisfy agency requirements. The procurement is classified under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a small business size standard of 1,000 employees. This radiopharmaceutical product is specifically required for scanning and detection of Alzheimer's Disease at the Dayton facility. Delivery would be arranged through select third-party radiopharmacy partners including Cardinal, Pharmalogic, Huntsman, or BAMF locations.

The primary purpose of this Special Notice is to inform the contracting community of the VA's intent to conduct a non-competitive procurement while providing an opportunity for other potential suppliers to demonstrate their capabilities. Businesses that believe they can provide equivalent supplies must submit written capabilities information to Contracting Officer Gina P. Crank at gina.crank@va.gov by September 16, 2025, at 5:00 PM local time, with "RFQ 36C25025Q0945 F18 Vizamyl Dayton" in the subject line. All capability responses must be provided at no cost or obligation to the government and will be used solely to determine whether the procurement should be opened to competitive bidding. The VA retains full discretion to maintain the sole-source approach regardless of any responses received. No formal solicitation is currently available, and all inquiries must be submitted via email to the designated contracting officer.